Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide for Tobacco Use in Smokers With Obesity
NCT06986993Phase 4Recruiting
- Sponsor
- University of Oklahoma
- Start
- Jul 2024
- Primary completion
- May 2028
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in Tobacco Use Disorder (TUD), sponsored by University of Oklahoma. Started Jul 2024; status: recruiting.
02
Drugs
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT06986993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06986993.